Evaluation of the Ability of Emergency Room Doctors at a French University Hospital Center to Identify Adverse Drug Events.
Journal
Journal of patient safety
ISSN: 1549-8425
Titre abrégé: J Patient Saf
Pays: United States
ID NLM: 101233393
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
pubmed:
27
2
2020
medline:
25
11
2021
entrez:
27
2
2020
Statut:
ppublish
Résumé
Numerous adverse drug events (ADEs) are not identified by doctors in medical emergencies, and they are a barrier to optimal treatment of patients. Identification of the factors that influence awareness of ADEs by doctors could allow events that compromise patient safety to be avoided. The aims of this study were to quantify the recognition of ADEs by emergency room (ER) doctors and to identify the factors associated with the lack of identification of drug-related risks. This study was carried out at the ER of a French teaching hospital between January 1, 2014, and the December 31, 2017. A previously used form was administered to the patients being treated in the ER, and it was completed using medical files to identify ADEs. The ADEs were then validated by a doctor and a senior pharmacist. Of the 1870 included patients, 279 (14.9%) exhibited an ADE. Of these 279 ADEs, 201 (72%) had been identified by the doctor. The probability of an ADE being identified was higher when the drug was directly linked with the main ailment of the patient (odds ratio, 1.72; 95% confidence interval, 1.01-2.97). Adverse drug events were identified less well when their severity was limited (spontaneous regression without treatment) (odds ratio, 0.5; 95% confidence interval, 0.27-0.93). This study showed that ADEs are identified less well when their severity is limited, as well as when the ADE is not directly linked with the main ailment of the patient.
Identifiants
pubmed: 32101954
pii: 01209203-202106000-00032
doi: 10.1097/PTS.0000000000000650
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e355-e359Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors disclose no conflict of interest.
Références
Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med . 2004;140:795–801.
Morimoto T, Gandhi TK, Seger AC. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care . 2004;13:306–314.
DRESS 2004. Available at: https://drees.solidarites-sante.gouv.fr/etudes-et-statistiques/publications/etudes-et-resultats/article/les-evenements-indesirables-graves-lies-aux-soins-observes-dans-les . Accessed October 1, 2019.
DRESS 2009: Etude ENEIS. Available at: https://drees.solidarites-sante.gouv.fr/etudes-et-statistiques/la-drees/colloques/archives-des-colloques-et-manifestations/article/colloque-sur-les-evenements-indesirables-associes-aux-soins-du-24-Novembre-2010 . Accessed October 1, 2019.
Institute of Medicine (US) Committee on Quality of Health Care in America. To Err Is Human: Building a Safer Health System. Kohn LT, Corrigan JM, Donaldson MS, eds. Washington, DC: National Academies Press (US); 2000. Available at: http://www.ncbi.nlm.nih.gov/books/NBK225182/ . Accessed July 2, 2019.
Becker ML, Kallewaard M, Caspers PW, et al. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf . 2007;16:641–651.
Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy . 2002;22:915–923.
Calderón-Ospina C, Orozco-Díaz J. Adverse drug reactions as the reason for visiting an emergency department. Rev Salud Publica (Bogota) . 2008;10:315–321.
Ventura MT, Laddaga R, Cavallera P, et al. Adverse drug reactions as the cause of emergency department admission: focus on the elderly. Immunopharmacol Immunotoxicol . 2010;32:426–429.
Zanocchi M, Tibaldi V, Amati D, et al. Adverse drug reactions as cause of visit to the emergency department: incidence, features and outcomes [in Italian]. Recenti Prog Med . 2006;97:381–388.
Cagliano S, Addobbati A. Adverse drug reactions in emergency department [in Italian]. Assist Inferm Ric . 2010;29:78–85.
Field TS, Gilman BH, Subramanian S, et al. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care . 2005;43:1171–1176.
Wu C, Bell CM, Wodchis WP. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug Saf . 2012;35:769–781.
Smith KM, McAdams JW, Frenia ML, et al. Drug-related problems in emergency department patients. Am J Health Syst Pharm . 1997;54:295–298.
Foucher N, Pinaud V, Van Tricht M, et al. Observatoire de la iatrogénie médicamenteuse dans un service d’urgences: amelioration du repérage des EIM (événements iatrogènes médicamenteux) par les médecins après 4 années d’expérience. Pharm Hosp Clin 1 févr . 2012;47:S35.
Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol . 2003;13:176–181.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther . 1981;30:239–245.
Nickel CH, Ruedinger JM, Messmer AS, et al. Drug-related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma Resusc Emerg Med J . 2013;21:15.
Laroche M-L, Boqueho S, Vallejo C, et al. Effets indésirables médicamenteux aux urgences: une étude prospective au CHU de Limoges. J Eur Urgences . 2008;21:64–69.
Roulet L, Ballereau F, Hardouin JB, et al. Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital. Emerg Med J EMJ . 2012;30.
Robinson RL, Burk MS. Identification of drug-drug interactions with personal digital assistant-based software. Am J Med . 2004;116:357–358.
Sancar M, Kasik A, Okuyan B, et al. Determination of potential drug–drug interactions using various software programs in a community pharmacy setting. Turk J Pharm Sci . 2019;16:14–19.
Hohl CM, Zed PJ, Brubacher JR, et al. Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Ann Emerg Med . 2010;55:493–502:e4.
Sackett DL, Straus SE. Finding and applying evidence during clinical rounds: the “evidence cart”. JAMA . 1998;280:1336–1338.
Sikdar KC, Alaghehbandan R, MacDonald D, et al. Adverse drug events in adult patients leading to emergency department visits. Ann Pharmacother . 2010;44:641–649.
Honigman B, Lee J, Rothschild J, et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc . 2001;8:254–266.
Tipping B, Kalula S, Badri M. The burden and risk factors for adverse drug events in older patients—a prospective cross-sectional study. S Afr Med J . 2006;96:1255–1259.
Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc . 1991;39:1093–1099.
Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med . 2003;348:1556–1564.
Helldén A, Bergman U, von Euler M, et al. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging . 2009;26:595–606.
Fauchais A-L, Ploquin I, Ly K, et al. Iatrogénie chez le sujet âgé de plus de 75 ans dans un service de posturgences. Étude prospective de cohorte avec suivi à six mois. Rev Médecine Interne . 2006;27:375–381.
Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med . 2008;19:505–510.
Santucci R, Levêque D, Herbrecht R, et al. Medication adverse events: impact of pharmaceutical consultations during the hospitalization of patients [in French]. Ann Pharm Fr . 2014;72:440–450.